Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantMSD PHARMA (SINGAPORE) PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
SUBCUTANEOUS
Medical Information
C02KX06
Manufacturer Information
MSD PHARMA (SINGAPORE) PTE. LTD.
Patheon Italia S.p.A
Active Ingredients
Documents
Package Inserts
Winrevair Injection vial PI.pdf
Approved: September 20, 2024